ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 90 filers reported holding ALLOVIR INC in Q1 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $59,478 | -44.5% | 15,096 | -27.8% | 0.03% | -41.1% |
| Q4 2022 | $107,248 | +51.1% | 20,906 | +99.8% | 0.06% | +75.0% |
| Q1 2022 | $71,000 | -50.3% | 10,463 | -5.5% | 0.03% | -40.7% |
| Q4 2021 | $143,000 | -39.1% | 11,076 | +18.3% | 0.05% | -47.6% |
| Q3 2021 | $235,000 | +20.5% | 9,359 | -5.0% | 0.10% | +28.8% |
| Q2 2021 | $195,000 | +11.4% | 9,854 | +31.8% | 0.08% | +8.1% |
| Q1 2021 | $175,000 | -37.9% | 7,478 | +1.9% | 0.07% | -36.8% |
| Q4 2020 | $282,000 | – | 7,339 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |